| Original language | English |
|---|---|
| Pages (from-to) | 301-304 |
| Number of pages | 4 |
| Journal | British Journal of Haematology |
| Volume | 191 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published or Issued - 1 Oct 2020 |
Keywords
- B-ALL
- Leukaemia
- PAX5
- Ph-like
- hypereosinophilia
ASJC Scopus subject areas
- Hematology
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: British Journal of Haematology, Vol. 191, No. 2, 01.10.2020, p. 301-304.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse
AU - McClure, Barbara J.
AU - Heatley, Susan L.
AU - Rehn, Jacqueline
AU - Breen, James
AU - Sutton, Rosemary
AU - Hughes, Timothy P.
AU - Suppiah, Ram
AU - Revesz, Tamas
AU - Osborn, Michael
AU - White, Daniel
AU - Yeung, David T.
AU - White, Deborah L.
N1 - Funding Information: The authors would like to thank Genetics and Molecular Pathology at SA Pathology, Adelaide, SA, Australia for performing the Cytogenetics, FISH and SNP. DLW is an National Health and Medical Research Council (NHMRC) Career Development Fellow and a Beat Cancer Principal Research Fellow. DTY is an NHMRC Early Career Fellow. TPH is a Beat Cancer Chair. SLH is The Kids' Cancer Project Fellow. Funding from NHMRC, Bristol‐Meyers Squibb Company, Tour de Cure Australia and the Leukaemia Foundation Australia (to DLW). Funding Information: DLW receives research support from BMS, and Honoraria from BMS and AMGEN. DTY receives research support from BMS & Novartis, and Honoraria from BMS, Novartis, Pfizer and AMGEN. TPH receives research support from BMS & Novartis, and Honoraria from BMS, Novartis, and Fusion Pharma. None of these agencies have had a role in the preparation of this manuscript. All other authors declare no conflicts of interest. Funding Information: The authors would like to thank Genetics and Molecular Pathology at SA Pathology, Adelaide, SA, Australia for performing the Cytogenetics, FISH and SNP. DLW is an National Health and Medical Research Council (NHMRC) Career Development Fellow and a Beat Cancer Principal Research Fellow. DTY is an NHMRC Early Career Fellow. TPH is a Beat Cancer Chair. SLH is The Kids' Cancer Project Fellow. Funding from NHMRC, Bristol-Meyers Squibb Company, Tour de Cure Australia and the Leukaemia Foundation Australia (to DLW).
PY - 2020/10/1
Y1 - 2020/10/1
KW - B-ALL
KW - Leukaemia
KW - PAX5
KW - Ph-like
KW - hypereosinophilia
UR - https://www.scopus.com/pages/publications/85088808129
U2 - 10.1111/bjh.17002
DO - 10.1111/bjh.17002
M3 - Letter
C2 - 32731299
AN - SCOPUS:85088808129
SN - 0007-1048
VL - 191
SP - 301
EP - 304
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 2
ER -